Phase 1 Study of Erlotinib Plus Radiation Therapy in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Open Access
- 1 April 2013
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 85 (5), 1275-1281
- https://doi.org/10.1016/j.ijrobp.2012.09.030
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Cetuximab in Refractory Skin Cancer TreatmentJournal of Cancer, 2012
- EGFR expression in advanced head and neck cutaneous squamous cell carcinomaHead & Neck, 2011
- Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancerCancer, 2011
- Outcomes of Recurrent Head and Neck Cutaneous Squamous Cell CarcinomaJournal of Skin Cancer, 2011
- Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck CancerJournal of Clinical Oncology, 2010
- Improvements in the Staging of Cutaneous Squamous-Cell Carcinoma in the 7th Edition of the AJCC Cancer Staging ManualAnnals of Surgical Oncology, 2010
- Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patientsJournal of the American Academy of Dermatology, 2006
- Treatment with gefitinib (ZD 1839) in a patient with advanced cutaneous squamous cell carcinomaBritish Journal of Dermatology, 2005
- An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck CancerJournal of Clinical Oncology, 2003
- Cutaneous Squamous-Cell CarcinomaThe New England Journal of Medicine, 2001